Loading clinical trials...
Loading clinical trials...
This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hillerod Hospital, Denmark
Collaborators
NCT06748209 · Treatment Resistant Major Depression
NCT02122562 · Magnetic Resonance Imaging, Major Depression, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT06732284 · Major Depression, Sleep Inertia
NCT02434393 · Major Depression, Late Life Depression (LLD)
Psychiatric Research Unit, Hillerod Hospital
Hillerød
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions